| Typicality: | 0.410 |
| Saliency: | 0.375 |
| for the treatment of unresectable melanoma | 7 | purpose |
| for another purpose | 4 | purpose |
| recently | 3 | temporal |
| drug → be approved in → japan | 50 |
| negative | neutral | positive |
| 0.058 | 0.606 | 0.336 |
| Raw frequency | 50 |
| Normalized frequency | 0.375 |
| Modifier score | 0.500 |
| Perplexity | 81.238 |